These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 16688622

  • 1. Topiramate in migraine prophylaxis: data from a pooled analysis and open-label extension study.
    Bussone G, Usai S, D'Amico D.
    Neurol Sci; 2006 May; 27 Suppl 2():S159-63. PubMed ID: 16688622
    [Abstract] [Full Text] [Related]

  • 2. Long-term migraine prevention with topiramate: open-label extension of pivotal trials.
    Rapoport A, Mauskop A, Diener HC, Schwalen S, Pfeil J.
    Headache; 2006 May; 46(7):1151-60. PubMed ID: 16866719
    [Abstract] [Full Text] [Related]

  • 3. Topiramate 100 mg/day in migraine prevention: a pooled analysis of double-blind randomised controlled trials.
    Bussone G, Diener HC, Pfeil J, Schwalen S.
    Int J Clin Pract; 2005 Aug; 59(8):961-8. PubMed ID: 16033621
    [Abstract] [Full Text] [Related]

  • 4. Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial.
    Diener HC, Agosti R, Allais G, Bergmans P, Bussone G, Davies B, Ertas M, Lanteri-Minet M, Reuter U, Sánchez Del Río M, Schoenen J, Schwalen S, van Oene J, TOPMAT-MIG-303 Investigators Group.
    Lancet Neurol; 2007 Dec; 6(12):1054-62. PubMed ID: 17988947
    [Abstract] [Full Text] [Related]

  • 5. Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial.
    Winner P, Pearlman EM, Linder SL, Jordan DM, Fisher AC, Hulihan J, Topiramate Pediatric Migraine Study Investigators.
    Headache; 2005 Dec; 45(10):1304-12. PubMed ID: 16324162
    [Abstract] [Full Text] [Related]

  • 6. Topiramate in migraine prevention: evidence-based medicine from clinical trials.
    Silberstein SD.
    Neurol Sci; 2004 Oct; 25 Suppl 3():S244-5. PubMed ID: 15549548
    [Abstract] [Full Text] [Related]

  • 7. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
    Diener HC, Bussone G, Van Oene JC, Lahaye M, Schwalen S, Goadsby PJ, TOPMAT-MIG-201(TOP-CHROME) Study Group.
    Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
    [Abstract] [Full Text] [Related]

  • 8. Topiramate for migraine prevention in adolescents: a pooled analysis of efficacy and safety.
    Winner P, Gendolla A, Stayer C, Wang S, Yuen E, Battisti WP, Nye JS.
    Headache; 2006 Jul; 46(10):1503-10. PubMed ID: 17115983
    [Abstract] [Full Text] [Related]

  • 9. Rizatriptan for treatment of acute migraine in patients taking topiramate for migraine prophylaxis.
    Seeburger JL, Cady RK, Winner P, MacGregor A, Valade D, Ge Y, Zhang Y, Hustad CM, Strickler N, Schaefer E, Connor KM, Ho TW.
    Headache; 2012 Jan; 52(1):57-67. PubMed ID: 22078129
    [Abstract] [Full Text] [Related]

  • 10. Topiramate: new indication. Migraine prevention: best avoided.
    Prescrire Int; 2006 Aug; 15(84):132-3. PubMed ID: 16989025
    [Abstract] [Full Text] [Related]

  • 11. Factors predicting the probability of relapse after discontinuation of migraine preventive treatment with topiramate.
    Schoenen J, Reuter U, Diener HC, Pfeil J, Schwalen S, Schäuble B, van Oene J.
    Cephalalgia; 2010 Nov; 30(11):1290-5. PubMed ID: 20959424
    [Abstract] [Full Text] [Related]

  • 12. Topiramate in migraine prevention.
    Silberstein SD.
    Headache; 2005 Apr; 45 Suppl 1():S57-65. PubMed ID: 15833091
    [Abstract] [Full Text] [Related]

  • 13. Topiramate in migraine prophylaxis: a randomised double-blind versus placebo study.
    Mei D, Capuano A, Vollono C, Evangelista M, Ferraro D, Tonali P, Di Trapani G.
    Neurol Sci; 2004 Dec; 25(5):245-50. PubMed ID: 15624081
    [Abstract] [Full Text] [Related]

  • 14. Topiramate intervention to prevent transformation of episodic migraine: the topiramate INTREPID study.
    Lipton RB, Silberstein S, Dodick D, Cady R, Freitag F, Mathew N, Biondi DM, Ascher S, Olson WH, Hulihan J.
    Cephalalgia; 2011 Jan; 31(1):18-30. PubMed ID: 20974598
    [Abstract] [Full Text] [Related]

  • 15. Topiramate in migraine prevention: results of a large controlled trial.
    Silberstein SD, Neto W, Schmitt J, Jacobs D, MIGR-001 Study Group.
    Arch Neurol; 2004 Apr; 61(4):490-5. PubMed ID: 15096395
    [Abstract] [Full Text] [Related]

  • 16. The impact of migraine on daily activities: effect of topiramate compared with placebo.
    Silberstein SD, Loder E, Forde G, Papadopoulos G, Fairclough D, Greenberg S.
    Curr Med Res Opin; 2006 Jun; 22(6):1021-9. PubMed ID: 16846536
    [Abstract] [Full Text] [Related]

  • 17. Cost-minimization analysis comparing topiramate with standard treatments in migraine prophylaxis.
    Ergun H, Gulmez SE, Tulunay FC.
    Eur Neurol; 2007 Jun; 58(4):215-7. PubMed ID: 17827966
    [Abstract] [Full Text] [Related]

  • 18. Topiramate in patients with episodic migraine: reducing the risk for chronic forms of headache.
    Limmroth V, Biondi D, Pfeil J, Schwalen S.
    Headache; 2007 Jan; 47(1):13-21. PubMed ID: 17355489
    [Abstract] [Full Text] [Related]

  • 19. Topiramate for migraine prevention.
    Wenzel RG, Schwarz K, Padiyara RS.
    Pharmacotherapy; 2006 Mar; 26(3):375-87. PubMed ID: 16503717
    [Abstract] [Full Text] [Related]

  • 20. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
    Dodick DW, Freitag F, Banks J, Saper J, Xiang J, Rupnow M, Biondi D, Greenberg SJ, Hulihan J, CAPSS-277 Investigator Group.
    Clin Ther; 2009 Mar; 31(3):542-59. PubMed ID: 19393844
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.